Integral Diagnostics Limited

OTCPK:ITGD.F Stock Report

Market Cap: US$372.2m

Integral Diagnostics Past Earnings Performance

Past criteria checks 0/6

Integral Diagnostics's earnings have been declining at an average annual rate of -24.6%, while the Healthcare industry saw earnings growing at 5% annually. Revenues have been growing at an average rate of 14.9% per year.

Key information

-24.6%

Earnings growth rate

-28.4%

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate14.9%
Return on equity-19.3%
Net Margin-12.7%
Next Earnings Update27 Aug 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Integral Diagnostics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:ITGD.F Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23456-58260
30 Sep 23449-16260
30 Jun 2344125250
31 Mar 2341823240
31 Dec 2239521220
30 Sep 2237818210
30 Jun 2236115210
31 Mar 2236118210
31 Dec 2136022220
30 Sep 2135626220
30 Jun 2135131220
31 Mar 2133332210
31 Dec 2031532190
30 Sep 2029528180
30 Jun 2027623160
31 Mar 2026322180
31 Dec 1925021190
30 Sep 1924121210
30 Jun 1923221240
31 Mar 1922219230
31 Dec 1821117230
30 Sep 1820016220
30 Jun 1818915210
31 Mar 1818715210
31 Dec 1718515200
30 Sep 1718215200
30 Jun 1718015200
31 Mar 1717716190
31 Dec 1617516190
30 Sep 1617114180
30 Jun 1616811180
31 Mar 1616511170
31 Dec 1516211170
30 Sep 151578170
30 Jun 151515160
30 Jun 144310

Quality Earnings: ITGD.F is currently unprofitable.

Growing Profit Margin: ITGD.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ITGD.F is unprofitable, and losses have increased over the past 5 years at a rate of 24.6% per year.

Accelerating Growth: Unable to compare ITGD.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ITGD.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6%).


Return on Equity

High ROE: ITGD.F has a negative Return on Equity (-19.26%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies